STREM Chemicals Inc. is now selling tris(triphenylphosphine)(trifluoromethyl)copper(I) (Catalog Number 29-2955), a reagent useful in the fields of medicinal chemistry (drug discovery) and preparation of new agrochemical compounds. The product is obtained through a process developed at ICIQ by Dr. Vladimir Grushin, which has been protected by a US patent application by ICIQ. After some studies conducted at CSOL to ensure scalability, the product can now be purchased through STREM.
It offers innovative, tailor-made catalytic solutions for homogeneous transformations, including enantioselective reactions.
CSOL’s mission is to act as the link between the researchers’ expertise and the industry, as well as developing the researchers’ discoveries into industrial applications with a comprehensive approach.